Z-Uncategorized | Physician's Weekly
Advertisement

Z-Uncategorized

FDA Announces Update to Clozapine REMS

Schizophrenia drug will require patients to be re-enrolled, prescribers re-certified The FDA announced an update to the Risk Evaluation and Mitigation Strategy (REMS) for the schizophrenia drug clozapine.The changes, which will...

Loading

Advertisement

For latest news and updates
Email-id is invalid